Martha Morrell insider trades

Open-market stock purchases and sales by Martha Morrell, CHIEF MEDICAL OFFICER at NeuroPace Inc, from SEC Form 4 filings since Jun 4, 2021.

Recent trades

DateStockTradeValue
Sep 24, 2026NPCE NeuroPace IncSold (not open market)$4.7K
Aug 27, 2026NPCE NeuroPace IncSold (not open market)$5.1K
Jun 24, 2026NPCE NeuroPace IncSold (not open market)$5.4K
May 27, 2026NPCE NeuroPace IncSold (not open market)$6.1K
May 15, 2026NPCE NeuroPace IncBought (not open market)—
May 15, 2026NPCE NeuroPace IncBought (not open market)—
Mar 24, 2026NPCE NeuroPace IncSold (not open market)$17.8K
Mar 3, 2026NPCE NeuroPace IncSold (not open market)$18.5K
Feb 27, 2026NPCE NeuroPace IncSold (not open market)$5.2K
Feb 20, 2026NPCE NeuroPace IncSold (not open market)$48.9K
Dec 15, 2025NPCE NeuroPace IncSold$399K
Dec 3, 2025NPCE NeuroPace IncSold (not open market)$22.3K
Nov 27, 2025NPCE NeuroPace IncSold (not open market)$5.9K
Nov 20, 2025NPCE NeuroPace IncSold (not open market)$41.2K

Companies traded

  • NPCE NeuroPace Inc: 16 sales, last Sep 24, 2026

Get free alerts when Martha Morrell files a new trade →